Treating multiple sclerosis
Although there is still no cure for multiple sclerosis (MS), effective strategies are available to modify the disease course; treat exacerbations that are also called attacks, relapses, or flare-ups; manage symptoms; improve function and safety; and provide emotional support. In combination, these treatments enhance the quality of life for people living with MS.
Modifying the disease course
The following FDA-approved disease-modifying agents can reduce disease activity and disease progression for many individuals with relapsing forms of MS, including those with secondary progressive disease who continue to have relapses.
- Avonex (interferon beta-1a)
- Betaseron (interferon beta-1b)
- Copaxone (glatiramer acetate)
- Extavia (interferon beta-1b)
- Gilenya (fingolimod)
- Novantrone (mitoxantrone)
- Rebif (interferon beta-1a)
- Tysabri (natalizumab)
Source: National MS Society